1. Home
  2. About
  3. CIRB Studies

CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

1137 results.
Study Number Lead Group Study Title CIRB Study Status
INT21-05-01 CLO-Northwestern University Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome Cancer Prevention and Control CIRB Available to Open
EAQ221CD ECOG-ACRIN Improving Medication Adherence in Metastatic Breast Cancer using a CONnected CUstomized Treatment Platform (CONCURxP) Cancer Prevention and Control CIRB Available to Open
EA2185 ECOG-ACRIN Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs Cancer Prevention and Control CIRB Available to Open
A211701 Alliance A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort Cancer Prevention and Control CIRB Completed
WF-97415 NCORP-Wake Forest University Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT) Cancer Prevention and Control CIRB Available to Open
MAY2015-05-01 CP-CTNet_CLO-Mayo Clinic Randomized, double-blind, placebo-controlled trial of Meriva® (curcuminoids) as a candidate chemoprevention agent for gastric carcinogenesis Cancer Prevention and Control CIRB Available to Open
A211901 Alliance Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions Cancer Prevention and Control CIRB Available to Open
1137 results.